6 results
8-K
EX-3.1
RPRX
Royalty Pharma Plc
31 Jan 18
Completion of Acquisition or Disposition of Assets
12:00am
8-K
EX-3.2
RPRX
Royalty Pharma Plc
31 Jan 18
Completion of Acquisition or Disposition of Assets
12:00am
8-K
EX-3.1
RPRX
Royalty Pharma Plc
15 Oct 10
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
EX-3.1
RPRX
Royalty Pharma Plc
19 Nov 09
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
EX-3.1
RPRX
Royalty Pharma Plc
23 Dec 08
Repros Therapeutics Inc. Board of Directors Elects Mark Lappe of Efficacy Capital as Its Chairman of the Board
12:00am
8-K
EX-3.1
pvfj9osj
2 May 06
Zonagen Reports First Quarter 2006 Financial Results
12:00am
- Prev
- 1
- Next